The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Increases in plasma neuropeptide Y concentrations during sympathetic activation in man
Abstract
Neuropeptide Y (NPY) coexists with noradrenaline in postganglionic sympathetic neurons. In order to test the hypothesis that NPY may be released along with catecholamines by activation of the sympathoadrenal system we measured plasma NPY-like immunoreactivity (NPY-LI) concentrations during cold pressor test, head up tilt and bicycle exercise in healthy volunteers. All 3 manoeuvres resulted in elevation of blood pressure, heart rate and plasma noradrenaline and adrenaline concentrations. These were accompanied by increases in plasma NPY-LI concentrations on cold pressor test and exercise, but not with head up tilt. The increases in both NPY-LI and catecholamines were greatest with exercise. These findings suggest that NPY is released at the same time as noradrenaline when sympathetic noradrenergic nerves are activated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NPY is an excellent indicator of sympathetic activity, 34 which is more stable and has a significantly longer half life in plasma.35”
Citations
Cites
Some statistical methods useful in circulation research.
Wallenstein, S., Zucker, C. L., & Fleiss, J. L. (1980) · Circulation Research · doi:10.1161/01.res.47.1.1 · Cited by 3,867
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,254
Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., Martling, C., Tatemoto, K., Mutt, V., Polak, J. M., Bloom, S. R., & Goldstein, M. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07171.x · Cited by 1,199
Everitt, B. J., Hökfelt, T. G. M., Terenius, L. Y., Tatemoto, K., Mutt, V., & Goldstein, M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90036-8 · Cited by 871
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers
Ekblad, E., Edvinsson, L. I., Wahlestedt, C., Uddman, R., Håkanson, R., & Sundler, F. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90064-8 · Cited by 741
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man
Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., & Goldstein, M. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90401-9 · Cited by 616
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Smedes, F., Kraak, J. C., & Poppe, H. (1982) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80506-x · Cited by 421
Fried, G. M., Terenius, L. Y., Hökfelt, T. G. M., & Goldstein, M. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-02-00450.1985 · Cited by 261
Co-release of neuropeptide Y and catecholamines during physical exercise in man
Lundberg, J. M., Martinsson, A., Hemsén, A., Theodorsson, E., Svedenhag, J., Ekblom, B. T., & Hjemdahl, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91837-6 · Cited by 223
Cited by
Sorted by citations
Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1611 · Cited by 656
Plasma neuropeptide-Y concentrations in humans exposed to military survival training
Morgan, C. A., Wang, S., Southwick, S. M., Rasmusson, A., Hazlett, G., Hauger, R. L., & Charney, D. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00239-5 · Cited by 298
Neuropeptide Y: the universal soldier
Pedrazzini, T., Pralong, F. P., & Grouzmann, E. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300029 · Cited by 289
Kaye, D. M., Lambert, G. W., Lefkovits, J., Morris, M. J., Jennings, G., & Esler, M. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90738-2 · Cited by 285
Release of mast cell mediators into the jejunum by cold pain stress in humans
Santos, J., Saperas, E., Nogueiras, C., Mourelle, M., Antolín, M., Cadahia, A., & Malagelada, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70577-3 · Cited by 237
Neuropeptide Y as an autonomic neurotransmitter
Potter, E. K. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90028-9 · Cited by 233
Żukowska-Grójec, Z. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44683.x · Cited by 229
Beneficial Effects from β-Adrenergic Blockade in Elderly Patients Undergoing Noncardiac Surgery
Zaugg, M., Tagliente, T. M., Lucchinetti, E., Jacobs, E., Krol, M., Bodian, C., Reich, D. L., & Silverstein, J. H. (1999) · Anesthesiology · doi:10.1097/00000542-199912000-00020 · Cited by 221
Chen, H., Vlahos, R., Bozinovski, S., Jones, J., Anderson, G. P., & Morris, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300597 · Cited by 164
“NPY-like immunoreactivity in the various brain regions was measured by a specific radioimmunoassay developed in our laboratory using synthetic NPY as standard (10–1280 pg/tube, Auspep, Australia) (Morris et al, 1986).”
Self-citationAutonomic function and rheumatoid arthritis—A systematic review
Adlan, A., Lip, G. Y. H., Paton, J. F. R., Kitas, G. D., & Fisher, J. P. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.06.003 · Cited by 122
“Plasma neuropeptide Y(41) Peripheral marker peptide released with norepinephrine following sympathetic activation.”
BackgroundVelkoska, E., Cole, T. J., & Morris, M. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2004 · Cited by 128
“NPY-like immunoreactivity (NPY-LI) was measured using synthetic NPY as a standard (10 -1280 pg/tube, Auspep, Australia) and Bolton Hunter labelled 125 I-NPY (2000 Ci/mmol, Amersham Pharmacia Biotech UK, Buckinghamshire HP, England) (41).”
MethodKallio, J., Pesonen, U., Kaipio, K., Karvonen, M., Jaakkola, U., Heinonen, O. J., Uusitupa, M., & Koulu, M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0436fje · Cited by 143
Neuropeptides in the sympathetic system: Presence, plasticity, modulation, and implications
Benarroch, E. E. (1994) · Annals of Neurology · doi:10.1002/ana.410360105 · Cited by 117
Straub, R. H., Herfarth, H., Falk, W., Andus, T., & Schölmerich, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00047-4 · Cited by 115
“Since norepinephrine is rapidly oxidized, the more stable neuropeptide Y (NPY) is often used as an indicator of the activity of the sympathetic nervous system (Morris et al., 1986; Hulting et al., 1990).”
BackgroundHärle, P., Straub, R. H., Wiest, R., Mayer, A., Schölmerich, J., Atzeni, F., Carrabba, M., Cutolo, M., & Sarzi-Puttini, P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038059 · Cited by 114
Origin and Actions of Neuropeptide Y in the Cardiovascular System
Żukowska-Grójec, Z., & Wahlestedt, C. (1993) · Humana Press eBooks · doi:10.1007/978-1-59259-465-8_8 · Cited by 109
Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans
Morris, M. J., Cox, H. S., Lambert, G. W., Kaye, D. M., Jennings, G., Meredith, I. T., & Esler, M. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.137 · Cited by 107
Hansen, M. J., Jovanovska, V., & Morris, M. J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02217.x · Cited by 105
Johnson, B. D., van Helmond, N., Curry, T. B., van Buskirk, C. M., Convertino, V. A., & Joyner, M. J. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00070.2014 · Cited by 96
Mannerås, L., Cajander, S. B., Lönn, M., & Stener‐Victorin, E. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90947.2008 · Cited by 95
Cigarette Smoke Exposure Reprograms the Hypothalamic Neuropeptide Y Axis to Promote Weight Loss
Chen, H., Hansen, M. J., Jones, J. E. C., Vlahos, R., Bozinovski, S., Anderson, G. P., & Morris, M. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-977oc · Cited by 93
“radioimmunoassay developed in our laboratory (33) using synthetic NPY as standard (10-1280 pg/tube, Auspep, Australia).”
MethodHaass, M., Cheng, B., Richardt, G., Lang, R. E., & Sch�mig, A. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165129 · Cited by 89
“by physical exercise, a parallel increase in plasma concentrations of noradrenaline and NPY was observed, suggesting release of both transmitters from stimulated sympathetic nerve fibres (Lundberg et al. 1985a; Morris et al. 1986).”
BackgroundEffects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite
Stadler, M., Tomann, L., Storka, A., Wolzt, M., Peric, S., Bieglmayer, C., Pacini, G., Dickson, S. L., Brath, H., Bech, P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0590 · Cited by 84
Release of immunoreactive-neuropeptide Y by rat platelets
Myers, A. K., Farhat, M. Y., Vaz, C. A., Keiser, H. R., & Żukowska-Grójec, Z. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81057-x · Cited by 74
Morris, M. J., Tortelli, C. F., Filippis, A., & Proietto, J. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00100-1 · Cited by 73
Hansen, M. J., Ball, M. J., & Morris, M. J. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03246-7 · Cited by 72
Adaptogens Stimulate Neuropeptide Y and Hsp72 Expression and Release in Neuroglia Cells
Panossian, A. G., Wikman, G., Kaur, P., & Asea, A. A. A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00006 · Cited by 71
“However, in the brain NPY acts as an anxiolytic and inhibits sympathetic activity which results in lowering blood pressure and heart rate (Morris et al., 1986; Kuo et al., 2007), and inhibiting the production of cortisol in human adrenal cells (Kempna et al.”
BackgroundWarnes, K. E., Morris, M. J., Symonds, M. E., Phillips, I., Clarke, I. J., Owens, J. A., & McMillen, I. C. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00172.x · Cited by 67
Haas, D. A., & George, S. R. (1989) · Brain Research · doi:10.1016/0006-8993(89)91112-8 · Cited by 68
Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders
Nahvi, R. J., & Sabban, E. L. (2020) · Biomolecules · doi:10.3390/biom10091248 · Cited by 67
Velkoska, E., Cole, T. J., Dean, R. G., Burrell, L. M., & Morris, M. J. (2008) · Journal of Nutrition · doi:10.1093/jn/138.9.1622 · Cited by 64
Autonomic Dysfunction in Preeclampsia: A Systematic Review
Yousif, D., Bellos, I., Penzlin, A. I., Hijazi, M. M., Illigens, B. M. W., Pintér, A., & Siepmann, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00816 · Cited by 63
Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines
Castagné, V., Corder, R., Gaillard, R. C., & Mormède, P. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90074-7 · Cited by 62
Neuropeptide Y and neurovascular control in skeletal muscle and skin
Hodges, G. J., Jackson, D. N., Mattar, L., Johnson, J. M., & Shoemaker, J. K. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00157.2009 · Cited by 58
Chen, H., Hansen, M. J., Jones, J. E. C., Vlahos, R., Anderson, G. P., & Morris, M. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2007 · Cited by 58
“NPY is released from the sympathetic nerves and the adrenal medulla, and plasma levels change in response to various stress conditions (38, 40, 41, 59).”
BackgroundLong-term cigarette smoke exposure increases uncoupling protein expression but reduces energy intake
Chen, H., Hansen, M. J., Jones, J. E. C., Vlahos, R., Anderson, G. P., & Morris, M. J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.067 · Cited by 57
“Brain NPY, plasma leptin, insulin and corticosterone assays As previously described (Morris et al., 1986) endogenous NPY from the various brain regions was extracted by boiling in 0.5M acetic acid, and measured by the radioimmunoassay developed in our laboratory using synthetic NPY as standard…”
MethodNeurohormonal changes in medical students during academic stress
AL-Ayadhi, L. Y. (2005) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2005.36 · Cited by 55
Furness, J. B., Koopmans, H. S., Robbins, H. L., Clerc, N., Tobin, J. M., & Morris, M. J. (2001) · Autonomic Neuroscience · doi:10.1016/s1566-0702(01)00311-3 · Cited by 50
Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome
FLETCHER, M. A., Rosenthal, M., Antoni, M. H., Ironson, G. H., Zeng, X. R., Barnes, Z. M., Harvey, J. M., Hurwitz, B. E., Levis, S., Broderick, G., et al. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-76 · Cited by 52
“Sympathoadrenal activation during the stress response results in increased release of epinephrine (E) and norepinephrine (NE) from the adrenal medulla, increased NE and NPY release from the sympathetic nerve endings and changes in blood flow to a variety of organs [48].”
BackgroundNeuropeptide Y Y1 receptors in vascular pharmacology
Franco‐Cereceda, A., & Liška, J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00242-8 · Cited by 52
Increased aggregation response of platelets in patients with inflammatory bowel disease
Andoh, A., Yoshida, T., Yagi, Y., Bamba, S., Hata, K., Tsujikawa, T., Kitoh, K., Sasaki, M., & Fujiyama, Y. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-005-1721-x · Cited by 50
Morris, M. J., Chen, H., Watts, R. P., Shulkes, A., & Cameron‐Smith, D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803716 · Cited by 48
Bloom, S. R., Edwards, A. V., & Jones, C. T. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017016 · Cited by 49
Functional organization of peripheral vasomotor pathways
Gibbins, I. L., Jobling, P., & Morris, J. L. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01079.x · Cited by 46
Chen, J., Zhao, X., Yue, G.-X., & Wang, Z. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9110-4 · Cited by 46
Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome
Simrén, M., Stotzer, P., Sjövall, H., Abrahamsson, H., & Björnsson, E. S. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200301000-00010 · Cited by 46
von Hörsten, S., Ballof, J., Helfritz, F., Nave, H., Meyer, D., Schmidt, R. E., Stalp, M., Klemm, A., Tschernig, T., & Pabst, R. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00349-x · Cited by 45
Stress elicits trans-synaptic activation of adrenal neuropeptide Y gene expression
Hiremagalur, B., Květňanský, R., Nankova, B. B., Fleischer, J., Geertman, R. T., Fukuhara, K., Viskupic, E., & Sabban, E. L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90194-5 · Cited by 44
Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
Feng, Q., Hedner, T., Andersson, B., Lundberg, J. M., & Waagstein, F. (1994) · Heart · doi:10.1136/hrt.71.3.261 · Cited by 42
Studies on the Mechanisms of Glucocorticoid Hypertension in Humans
Whitworth, J. A. (1994) · Blood Pressure · doi:10.3109/08037059409101518 · Cited by 42
Jackowski, A., Crockard, A., Burnstock, G., & Lincoln, J. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.45 · Cited by 42
SİVA, Z. O., Uludüz, D., Keskin, F. E., Erenler, F., Balcı, H., Uygunoğlu, U., Saip, S., Göksan, B., & Sıva, A. (2017) · Cephalalgia · doi:10.1177/0333102417748928 · Cited by 43
Identification and characterization of the emetic effects of peptide YY
Harding, R., & McDonald, T. J. (1989) · Peptides · doi:10.1016/0196-9781(89)90069-7 · Cited by 41
Unaltered TNF-alpha production by macrophages and monocytes in diet-induced obesity in the rat.
Bedoui, S., Velkoska, E., Bozinovski, S., Jones, J. E. C., Anderson, G. P., & Morris, M. J. (2005) · Journal of Inflammation · doi:10.1186/1476-9255-2-2 · Cited by 40
“Plasma leptin concentrations were measured using a commercially available radioimmunoassay kit (Linco, Missouri, USA) while NPY was measured using an in house assay utilising a rabbit antibody and 125I-NPY (2000 Ci/mmol, Amersham, Australia) as previously described [13].”
BackgroundMethodRole of Neuropeptide Y in Cold Stress-Induced Hypertension
Han, S., Chen, X., Cox, B. F., Yang, C.-L., Wu, Y., Naes, L., & Westfall, T. C. (1998) · Peptides · doi:10.1016/s0196-9781(97)00297-0 · Cited by 38
Uncoupling of sympathetic nervous system and hypothalamic‐pituitary‐adrenal axis in cirrhosis
Wiest, R., Moleda, L., Zietz, B., Hellerbrand, C., Schölmerich, J., & Straub, R. H. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05456.x · Cited by 37
Houtman, S., Oeseburg, B., & Hopman, M. T. E. (1999) · Clinical Physiology · doi:10.1046/j.1365-2281.1999.00166.x · Cited by 36
Fitzgerald, P. B., Scaffidi, A., Morris, M. J., de Castella, A. R., & Kulkarni, J. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.519 · Cited by 35
“NPY-like immunoreactivity (NPY-LI) was measured by a specific radioimmunoassay developed in our laboratory (Morris et al., 1986) using synthetic NPY as standard (10–1280 pg/tube, Auspep, Australia).”
MethodLehmann, J. C. (1990) · Drug Development Research · doi:10.1002/ddr.430190402 · Cited by 34
Haass, M., Hock, M., Richardt, G., & Sch�mig, A. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00260605 · Cited by 34
Endogenous Mediators in Sepsis and Septic Shock
Beishuizen, A., Vermes, I., & Haanen, C. (1998) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60206-1 · Cited by 33
Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart.
Komaru, T., Ashikawa, K., Kanatsuka, H., Sekiguchi, N., Suzuki, T., & Takishima, T. (1990) · Circulation Research · doi:10.1161/01.res.67.5.1142 · Cited by 32
Żukowska-Grójec, Z., Golczynska, M., Shen, G. H., Torres-Duarte, A. P., Haass, M., Wahlestedt, C., & Myers, A. K. (1993) · Pediatric Nephrology · doi:10.1007/bf01213372 · Cited by 31
“... brain [1], in postganglionic sympathetic noradrenergic nerves innervating the cardiovascular system, and in catecholamine-containing chromaffin cells of the adrenal medulla [2, 3]. NPY is stored in large densecore vesicles [4] and is coreleased with norepinephrine (NE), primarily during high-intensity sympathetic…”
BackgroundIs the CCK2 receptor essential for normal regulation of body weight and adiposity?
Chen, H., Kent, S., & Morris, M. J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05016.x · Cited by 31
“NPY-like immunoreactivity was measured by a specific radioimmunoassay developed in our laboratory (Morris et al., 1986) using synthetic NPY as standard (10–1280 pg ⁄ tube, Auspep, VIC,”
MethodKeast, J. R., Gleeson, R. J., Shulkes, A., & Morris, M. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00077-5 · Cited by 29
Subconstrictor Doses of Neuropeptide Y Potentiate α1-Adrenergic Venoconstriction In Vivo
Linder, L., Lautenschlager, B. M., & Haefeli, W. E. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.483 · Cited by 28
Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia
Khatun, S., Kanayama, N., Belayet, H. M., Bhuiyan, A. B., Jahan, S., Begum, A., Kobayashi, T., & Terao, T. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70342-5 · Cited by 28
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease
Zoccali, C., Mallamaci, F., Tripepi, G. L., Benedetto, F. A., Parlongo, S., Cutrupi, S., Bonanno, G., Rapisarda, F., Fatuzzo, P. M., Seminara, G., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200307000-00025 · Cited by 27
Involvement of neuropeptide Y in neuroendocrine stress responses. Central and peripheral studies
Mormède, P., Castagné, V., Rivet, J., Gaillard, R. C., & Corder, R. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9050-0_8 · Cited by 27
Hastings, J. A., Pavia, J. M., & Morris, M. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01475-8 · Cited by 26
Increased immunoreactive neuropeptide Y in platelets of spontaneously hypertensive rats (SHR)
Ogawa, T., Kitamura, K., Kawamoto, M., Eto, T., & Tanaka, K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92759-9 · Cited by 25
Rastmanesh, R., Salehi‐Abargouei, A., Shadman, Z., Ebrahimi, A. A., & Weber, C. E. (2008) · Journal of Pain · doi:10.1016/j.jpain.2008.03.006 · Cited by 24
Regional Sympathetic Effects of Low-Dose Clonidine in Heart Failure
Aggarwal, A., Esler, M., Morris, M. J., Lambert, G. W., & Kaye, D. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000055779.93635.a2 · Cited by 24
Brown, D. R., Boster, S. L., Overend, M. F., Parsons, A. M., & Treder, B. G. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90107-8 · Cited by 24
Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs
Poncet, M., Damase‐Michel, C., Tavernier, G., Tran, M. A., Berlan, M., Montastruc, J., & Montastruc, P. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14232.x · Cited by 23
Xia, J., Neild, T. O., & Kotecha, N. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14522.x · Cited by 22
NEUROPEPTIDE Y RADIO‐IMMUNOASSAY: CHARACTERIZATION AND APPLICATION
Allen, R. S., Boublik, J. H., Hauger, R. L., Scott, N., Rivier, J., & Brown, M. R. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01402.x · Cited by 22
Sundkvist, G., Bramnert, M., Bergström, B., Manhem, P., Lilja, B., & Ahrén, B. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90028-p · Cited by 21
Minson, R. B., McRitchie, R. J., & Chalmers, J. P. (1989) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(89)90095-7 · Cited by 21
Tidgren, B., Theodorsson, E., & Hjemdahl, P. (1991) · Clinical Physiology · doi:10.1111/j.1475-097x.1991.tb00649.x · Cited by 19
Neuroendocrine immune pathways in chronic arthritis
Capellino, S., & Straub, R. H. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.01.010 · Cited by 18
Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension
Wiest, R., Jurzik, L., Herold, T., Straub, R. H., & Schölmerich, J. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.044 · Cited by 19
“myocardial infarction, chronic heart failure or phaeochromocytoma [2,30,46,61,85].”
BackgroundNeuropeptide Y in the Sympathetic Control of Blood Pressure in Hypertensive Subjects
Chalmers, J. P., Morris, M. J., Kapoor, V., Cain, M., Elliott, J. M., Russell, A. E., Pilowsky, P. M., Minson, J. B., West, M., & Wing, L. M. H. (1989) · Clinical and Experimental Hypertension · doi:10.3109/10641968909045412 · Cited by 19
Post‐exercise depression of baroreflex slowing of the heart in humans
Ulman, L. G., Potter, E. K., McCloskey, D. I., & Morris, M. J. (1997) · Clinical Physiology · doi:10.1111/j.1365-2281.1997.tb00009.x · Cited by 18
Assessment of sympathoneural activity in clinical research
McCance, A. J. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90085-p · Cited by 17
Psychopharmacological possibilities in the acute disaster setting
Simon, A. B., & Gorman, J. M. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.03.004 · Cited by 18
Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas
Eurin, J., Barthélemy, C., Masson, F., Maistre, G., Soualmia, H., Noé, E., Sarfati, E., Eurin, B., & Carayon, A. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00092-0 · Cited by 18
Ciarleglio, A. E., Beinfeld, M. C., & Westfall, T. C. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90191-5 · Cited by 18
The sympathetic nervous system in healthy and hypertensive pregnancies: physiology or pathology?
Brislane, Á., Davenport, M. H., & Steinback, C. D. (2022) · Experimental Physiology · doi:10.1113/ep089665 · Cited by 17
“NPY is a potent vasoconstrictor peptide that is transmitted with noradrenaline at sympathetic nerve terminals after sympathetic stimulation (Morris et al., 1986; Wahlestedt et al., 1990).”
BackgroundUllman, B., Lindvall, K., Lundberg, J. M., Sigurðsson, A. F., & Swedberg, K. B. (1994) · Clinical Physiology · doi:10.1111/j.1475-097x.1994.tb00498.x · Cited by 17
Pavia, J. M., & Morris, M. J. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02523.x · Cited by 17
Morris, M. J., & Pavia, J. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.002 · Cited by 17
Sympathetic Neural Control in Humans with Anxiety‐Related Disorders
Bigalke, J. A., & Carter, J. R. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210027 · Cited by 29
Jacques, D., Sader, S., Perreault, C., Abdel-Samad, D., & Provost, C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-162 · Cited by 16
NEUROPEPTIDE Y IN CORTISOL‐INDUCED HYPERTENSION IN MALE VOLUNTEERS
Whitworth, J. A., Williamson, P. M., Brown, M. A., & Morris, M. J. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02538.x · Cited by 16
Jensen, E. W., Espersen, K., Kanstrup, I., & CHRISTENSEN, N. J. (1992) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1992.tb09277.x · Cited by 16
Changes in cardiac neuropeptide Y after experimental myocardial infarction in rat
Han, C., Wang, X., Fiscus, R. R., Gu, J., & McDonald, J. K. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90344-3 · Cited by 15
Zoccali, C. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200501000-00005 · Cited by 15
Ilebekk, A., Björkman, J., & Nordlander, M. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000177986.21929.d8 · Cited by 15
Lipnicki, D. M., & Drummond, P. D. (2001) · Clinical Autonomic Research · doi:10.1007/bf02322052 · Cited by 15
“The systemic concentration of neuropeptide Y increases during sympathetic activation [23], and with its long plasma half-life [24], could have accumulated over the course of the experiment.”
Metadata
- Authors
- Morris, M. J., Russell, A. E., Kapoor, V., Cain, M. D., Elliott, J. M., West, M. J., Wing, L. M. H., & Chalmers, J. P.
- Affiliations
- Flinders Medical Centre (AU)
- Venue
- Journal of the Autonomic Nervous System
- Publisher
- Elsevier BV
- Published
- 1986-10
- Volume
- 17
- Issue
- 2
- Pages
- 143-149
- ISSN
- 0165-1838 (ISSN-L)
- OpenAlex
- W2001937802
- Cited by
- 159
- References
- 22
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2017: 1 · 2014: 4 · 2013: 2 · 2012: 3
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the Autonomic Nervous System (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- neuropeptide Y, sympathetic activation, sympathoadrenal system, norepinephrine, catecholamines, epinephrine, cold pressor test, head-up tilt, physical activity, blood pressure, heart rate
- MeSH terms
- Adult, Blood Pressure, Chromatography, High Pressure Liquid, Cold Temperature, Epinephrine, Exercise Test, Female, Heart Rate, Humans, Immersion, Male, Middle Aged, Neuropeptide Y, Norepinephrine, Posture, Radioimmunoassay, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review